CorrespondenceResistance to second-line drugs in multidrug-resistant tuberculosis
References (3)
- et al.
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Lancet
(2012)
There are more references available in the full text version of this article.
Cited by (3)
In vitro and intracellular activity of 4-substituted piperazinyl phenyl oxazolidinone analogues against Mycobacterium tuberculosis
2014, Journal of Antimicrobial ChemotherapyPrinciples for designing future regimens for multidrug-resistant tuberculosis
2014, Bulletin of the World Health Organization
Copyright © 2013 Elsevier Ltd. All rights reserved.